Stay updated on Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page.

Latest updates to the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded locations Nantes Cedex 1 and Paris 7 to the study locations and updated the revision from v3.3.2 to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.3%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.3.2 added and v3.2.0 removed, reflecting internal document version updates without altering study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedRemoved the government funding/operational status notice from the page; the rest of the study details and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check66 days agoChange DetectedNo substantive changes to core study content; the visible updates appear to be cosmetic UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check95 days agoChange DetectedAdded a prominent operating-status notice and updated the version from v3.1.0 to v3.2.0; old version tag v3.1.0 was removed.SummaryDifference3%

- Check102 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page.